Regal Funds loses $100m following Opthea’s medical trial failure

MELBOURNE: Investors have wiped more than $100m from the value of Regal Funds, ... read more

Healthscope flatlining and clock is ticking on its demise

MELBOURNE: Investors are feeling the pain after one of Healthscope’s biggest landlords, a ... read more

Pathology firms watch budget as uplift to balance sheets intimated

CANBERRA: Among companies watching the budget tonight are likely to be pathology providers. ... read more

Sumitomo sells Healthscope debt as investors lose confidence

SYDNEY: Japan’s Sumitomo Mitsui Banking Corp has sold its loan in Healthscope, with ... read more